FDA Update Regarding Storm Damage at Pfizer Plant in North Carolina

The Food and Drug Administration (FDA) has released an update on the storm damage that occurred at a Pfizer facility in North Carolina. The agency is closely monitoring the situation and working with Pfizer to ensure the safety and quality of its products. Based on the FDA's initial analysis, Pfizer's North Carolina plant is the exclusive supplier of less than 10 drugs for the U.S. market. However, many of these drugs have alternative formulations or ample stock available in other Pfizer warehouses. The FDA has taken proactive measures to address any potential shortages by seeking additional sources and encouraging other manufacturers to increase production if necessary.  
The FDA will provide further updates as they become available.

by Staff